Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 283
Selected: 0
NCT IDTitle
NCT01887340Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
NCT04304924Motivating to Exercise and Diet, and Educating to Healthy Behaviors After Breast Cancer
NCT03314324A Study of Patient Preference Between ODM-201 and Enzalutamide in Men With Metastatic Castrate-resistant Prostate Cancer
NCT01459003Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer
NCT07001618Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
NCT00349505Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma
NCT01626638Confocal Micro-endoscopy in Head and Neck Cancer/Micro Endoscopie Confocale (MEC)Oto-Rhino-Laryngologie (ORL)
NCT00634777Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma
NCT00418327Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma
NCT02902874Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
NCT05215106Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)
NCT07016230Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)
NCT02997358Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma
NCT00181025Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle
NCT01566019Molecular Screening for Cancer Treatment Optimization
NCT06713798Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures
NCT00936156Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years
NCT03570021ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer
NCT05705687Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors
NCT03212469A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer
NCT05691608MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2
NCT04826198Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 Months
NCT00126269Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary
NCT00544349Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery
NCT05821790Role of the Tumor Microenvironment in Aggressive Meningiomas
NCT00126256Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer
NCT04965766Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer
NCT05705791Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma
NCT00410683Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery
NCT00359645Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population
NCT03983369Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults
NCT02115165A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors
NCT01784900Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab
NCT06439888Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer
NCT00162669Bevacizumab in Advanced Hepatocellular Carcinoma
NCT02063009Measurement of Cardiac Index Using an Implanted Central Venous Access Port in Patients Scheduled for Oncologic High-risk Surgery
NCT00367861Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance
NCT02131480Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma
NCT06902883Study on the Effectiveness and Comfort of Innovative Solutions for the Internal Transport of Patients in Wheelchairs in a Hospital Setting
NCT00162721The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas
NCT03323424Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers
NCT03604588Evaluation of HPV OncoTect ™ for the Etiological Diagnosis of HPV-induced Oropharyngeal Cancers
NCT03606070Multiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot Study
NCT02992912Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours
NCT06840782First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.
NCT01786031Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program
NCT01864850Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC
NCT02105168Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT04341207Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients
NCT00180856Radiofrequency Ablation of Lung Tumors